Discovery of a novel potent GPR40 full agonist

Discovery of a novel potent GPR40 full agonist The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470) Discovery of N -arylpyrroles as agonists of GPR120 for the treatment of type II diabetes Design, synthesis and biological evaluation of a series of novel GPR40 agonists containing nitrogen heterocyclic rings Discovery of a Potent Free Fatty Acid 1 Receptor Agonist with Low Lipophilicity, Low Polar Surface Area, and Robust in Vivo Efficacy Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists Design, synthesis and biological evaluation of novel FFA1/GPR40 agonists: New breakthrough in an old scaffold Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus Design, synthesis and structure–activity relationship studies of novel free fatty acid receptor 1 agonists bearing amide linker Novel free fatty acid receptor 1 (GPR40) agonists based on 1,3,4-thiadiazole-2-carboxamide scaffold